Editorial: Novel methods and technologies for the evaluation of drug outcomes and policies

Front Pharmacol. 2024 Apr 18:15:1396034. doi: 10.3389/fphar.2024.1396034. eCollection 2024.

Blythe Adamson^{1

2}, Amr Makady³, Grammati Sarri⁴, Omneya Mohamed⁵, Zaheer Babar⁶, Dalia M Dawoud^{7

8}

¹ Flatiron Health, New York, NY, United States.
² The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Seattle, WA, United States.
³ Janssen-Cilag B.V., Breda, Netherlands.
⁴ Cytel, London, United Kingdom.
⁵ Baxter AG Scientific Office, Dubai, United Arab Emirates.
⁶ Department of Pharmacy, University of Huddersfield, Huddersfield, United Kingdom.
⁷ Faculty of Pharmacy, Cairo University, Cairo, Egypt.
⁸ National Institute for Health and Care Excellence (NICE), London, United Kingdom.

No abstract available

Keywords: HEOR; analytic; artificial intelligence; causal inference; health technology assessment (HTA); methods.

Publication types